NCT00565591View on ClinicalTrials.gov

Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPI

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

February 29, 2008

Conditions
Allergic Asthma
Interventions
DRUG

Albuterol sulfate

Single dose dry powder by inhalation

Trial Locations (1)

52240

Iowa Clinical Research Corporation, Iowa City

All Listed Sponsors
lead

Respirics Inc.

INDUSTRY

NCT00565591 - Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPI | Biotech Hunter | Biotech Hunter